Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Using AS01 Adjuvant to Improve Immune Response in Older Adults Through Trained Immunity
NCT07527247Phase 2Recruiting
- Sponsor
- Singapore General Hospital
- Start
- Nov 2025
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in Infection (4 arms), sponsored by Singapore General Hospital. Primary endpoint: Host Immune Response at Day 84. Started Nov 2025; status: recruiting.
02
Conditions
Infection
Beyond the preview
Go deeper on NCT07527247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07527247.